Menu Back to Medical-and-Scientific-Communications-2016-Annual-Forum

Overview

March 20, 2016 - Core Curriculum*
March 21, 2016 - Tutorials (AM)*

March 21-23, 2016 - Forum

*Core Curriculum and Tutorials require registration and are an additional fee

This program has been developed in collaboration with the Medical Communications, Medical Writing, and Medical Science Liaison Communities.


Virtual Conference
Can't attend the live meeting?  Check out our Medical Affairs and Scientific Communications 2016 Annual Forum Virtual Conference

This is a must-attend annual forum for Medical Communication, Medical Information, Medical Science Liaison, and Medical Writing Professionals. The cross-functional general sessions and five breakout tracks encompass all areas including medical information, medical science liaison, medical communications, medical call center, and medical writing, so you can gain further expertise and networking opportunities in your own area as well as different functional areas. Nowhere else can you network with all these professionals in one location. This content is developed to meet the needs of those who work in biopharmaceutical industry based medical scientific communications by including three central tracks covering:

  • Medical Communications
  • Medical Writing: Regulatory and Publication
  • Medical Science Liaisons



Medical Communications Track
Health care professionals and patients look to Medical Communication and Medical Information professionals to provide essential, accurate, and unbiased drug information, therefore making medical communications an integral part of the health care industry. Because we work in the second most highly regulated industry, the industry professionals who provide these services need to have a comprehensive understanding of not only the medical content, but also the regulatory and compliance environment which directly affects their daily activities. As more regulatory guidances and federal laws are updated and enacted by congress, health care professionals providing drug information to patients and health care professionals on behalf of manufacturers must be trained and be fully aware of the scientific exchange environment they are working in. Medical information departments must adapt to meet the needs of the changing health care landscape and the variety of evolving stakeholders that rely on the information provided by companies. They must also find the most effective ways to utilize their customer input to enhancer their medical information services and to share the customer insights in an effective, action driven manner to business partners. Responses to requests for drug information (on-label or off-label) from health care professionals’ impact patient treatment decisions on a daily basis (including payers, access, and reimbursement). Therefore, a comprehensive understanding of federal guidances and laws for appropriate communications to patients and healthcare providers is essential. You will gain a better understanding of best practices within their job function and a broader awareness of the regulatory environment. You will also learn how to work better as part of interdisciplinary teams, practice evidence based medicine evaluation, and effectively use innovations in technology.

Medical Science Liaison Track
Medical Science Liasions (MSLs) play a vital role in establishing and sustaining important relationships with medical professionals, health care systems, academic institutions, and others within the medical product development field.  MSLs establish a culture of engagement, exchange scientific information, and develop collaborations among health care professionals in order to help foster advancements in medical product discovery.  As the MSL role continues to grow and evolve, there is a need to share insight, knowledge, and best practices among colleagues. 

This track will feature a wide range of topics for MSL professionals, including insight into the MSL role across the product life cycle, perspectives on the MSL career path, and globalization of the MSL role.  There will also be a joint session with the Medical Writing track on the topic of Health Economics Research Outcomes. You will learn best practices and for ensuring continued success within the MSL role, ways to advance the development of MSL operations, and solutions for engaging field based medical teams within the industry.

Medical Writing Track
Medical and scientific writers are responsible for authoring, editing, preparing, and planning publications and regulatory deliverables working within a large team. To stay informed of the latest developments in publication and regulatory writing, medical writers need to understand the new regulatory guidances and best practices with in the industry. The DIA Medical Affairs and Scientific Communications 2016 Annual Forum is a great opportunity for medical writing professionals to engage with experts in the field and learn how other medical writers resolve similar challenges at different companies. By making new connections with your professional colleagues, this opportunity to exchange ideas and develop new ones is invaluable.
 
This track will be subdivided into two tracks: Medical Writing Regulatory and Medical Writing Publications.  Included within these sub-tracks will be sessions on biosimilars and the communicator, GPP3, EMA Policy 70, ethical and accurate data in publications, bioethics, health economics and outcomes research, sponsor/vendor relationships, and career development.  This track is a great opportunity to develop, innovate, and advance your medical writing career.


Experience the Forum on the Go with the DIA Global App

Once you’re registered, use the DIA Global app to start preparing for the forum! Download the app to view the agenda and speakers, network with attendees and exhibitors, and get updates throughout the forum. Available for all Apple and Android products – just search “DIA Global” in your app store.


As a condition of registering for the DIA event, you acknowledge DIA’s right to record and stream, by any audio, video, or audio-visual means, the DIA event and your participation in the event, including your image, questions, and comments. You further acknowledge DIA’s right, as the sole and exclusive owner of the event, to use, reproduce, publish, license, sell, display, and distribute copies of the event in any print or electronic medium (such as CD-ROM or via the Internet) consistent with DIA’s nonprofit and tax exempt purposes. You agree to waive any right to royalties or compensation for any of the rights you have granted DIA.

Who should attend?

Professionals involved in:

  • Medical Communications
  • Medical Writing
  • Medical Liaisons
  • Medical Information
  • Medical Call Center Environment
  • Regulatory Affairs
  • Clinical Research
  • Professional Education, Training, and Development
  • Document Management/eSubmissions

Program Committee

  • Eileen  Girten, MS
    Eileen Girten, MS Principal Medical Writer
    Inventiv Health Clinical, United States
  • Craig J. Klinger, RPh
    Craig J. Klinger, RPh Consultant, Field Medical Liaison Strategy and Capabilities - Trainer
    Lilly USA, LLC, United States
  • Darryl Zachary L'Heureux, PhD, MPharm, MSc
    Darryl Zachary L'Heureux, PhD, MPharm, MSc Medical Writing Manager
    Bristol-Myers Squibb, United States
  • Julia  Petses, PharmD
    Julia Petses, PharmD Director, Medical Information Services, Diabetes
    Sanofi US, United States
  • Mary K. Sendi, PharmD
    Mary K. Sendi, PharmD Director - Team Lead, Pfizer Medical Information
    Pfizer Inc, United States
  • Kevin  Appareti, MBA
    Kevin Appareti, MBA Senior Director, Global Medical Science Liaison
    Philips HealthTech, United States
  • Maureen L. Baldwin, MSN, RN
    Maureen L. Baldwin, MSN, RN Associate Director, Medical Customer Interface
    Pfizer Inc., United States
  • J. Lynn  Bass
    J. Lynn Bass Senior Director, Medical Science Liaison (MSL) Operations
    TriNet Pharma, United States
  • Poonam A. Bordoloi, PharmD
    Poonam A. Bordoloi, PharmD Associate Director, Strategic Medical Communications and Innovation
    Celgene Corporation, United States
  • David  Bowers, PharmD
    David Bowers, PharmD Director, Medical Communications
    PPD, United States
  • Kathryn  Bucci, PharmD
    Kathryn Bucci, PharmD Medical Governance Lead
    Pfizer, Inc., United States
  • Ivy Lee Chang, PharmD
    Ivy Lee Chang, PharmD Associate Director, Medical Communications
    Genentech, Inc., A Member of the Roche Group, United States
  • Michael  Church, MA
    Michael Church, MA Senior Director, Strategic
    Inventiv Health Clinical, United States
  • Edmund J Cunningham, PharmD
    Edmund J Cunningham, PharmD Director, Medical Science Liaisons, Regional Lead
    Sunovion Pharmaceuticals, Inc., United States
  • Christine  Dale, MBA, MS
    Christine Dale, MBA, MS Independent Contract Writer
    XWrite, LLC, United States
  • Art  Gertel, MS
    Art Gertel, MS President and Principal Consultant
    MedSciCom, LLC, United States
  • Pete G. Guillot, CPA, MBA, RAC
    Pete G. Guillot, CPA, MBA, RAC President
    Centerfirst, United States
  • Jennie Grace Jacobson, PhD
    Jennie Grace Jacobson, PhD Consultant, Scientific Communications
    Eli Lilly and Company, United States
  • Juhi  Jaisinghani, PharmD
    Juhi Jaisinghani, PharmD Medical Information Therapeutic Manager
    Novo Nordisk Inc., United States
  • Lawrence Eugene Liberti, MS, RPh, RAC
    Lawrence Eugene Liberti, MS, RPh, RAC Executive Director
    Centre For Innovation In Regulatory Science (CIRS), United States
  • Christi C Marsh, PharmD, RPh
    Christi C Marsh, PharmD, RPh Director, UCBCares
    UCB, Inc., United States
  • Rebecca A. Vermeulen, RPh
    Rebecca A. Vermeulen, RPh Head, Global Medical Science Liaisons and Communication
    Hoffmann-La Roche Ltd., Switzerland
  • Robin  Whitsell
    Robin Whitsell President
    Whitsell Innovations, Inc., United States
  • Jim R. Wilkinson, PhD
    Jim R. Wilkinson, PhD Executive Director, Oncology Regional Medical Liaisons Global Scientific Affairs
    Amgen, Inc., United States
  • Ann M Winter-Vann, PhD
    Ann M Winter-Vann, PhD Senior Medical Writer and Consultant
    Whitsell Innovations, Inc., United States
Load More

Contact us

Registration Questions?

Send Email
1.888.257.6457
+1.215.442.6100


Agenda Details

Send Email
+1.215.442.6131


Event Logistics

Send Email
+1.215.442.6149


Exhibit Information

Send Email
+1.215.442.6132